Table of Contents Table of Contents
Previous Page  100 / 152 Next Page
Information
Show Menu
Previous Page 100 / 152 Next Page
Page Background

S96

Abstracts / Journal of Clinical Virology 82S (2016) S1–S142

Abstract no: 146

Presentation at ESCV 2016: Poster 151

Case report: Unexpected cause of respiratory

failure 3 days after heart transplantation

K. Dierickx

, A. Vankeerberghen, A. Boel,

K. Van Vaerenbergh, H. De Beenhouwer

Laboratory of Microbiology, OLVZ Aalst, Belgium

Respiratory syncytial virus is an RNA virus belonging to the

Paramyxoviridae and it is mostly found in young children. This

virus can also cause morbidity and mortality in immunocompro-

mised adults. Respiratory virus infection (RSV) is an important

complication in solid organ transplant patients but the longitudi-

nal monitoring of these infections has not been extensively studied.

Little has been described in literature regarding RSV pneumonia in

adult heart transplant patients.

Here we report an interesting case of a 56 year old female with

a history of non-ischemic cardiomyopathy starting in 2011. On

January the 3rd of 2015 she successfully underwent a heart trans-

plantation. Although there were no signs of respiratory disease at

the time of hospitalization she showed respiratory insufficiency

three days post-transplantation.

In the microbiology lab each respiratory sample is cultured and

when indicated screened for a panel of 22 targets detected in 8 in-

house RT-PCR multiplexes. This molecular panel covers the most

important pathogens of viral respiratory infections and atypical

bacterial pneumonia. The first respiratory sample of this patient

was a bronchial aspirate taken three days post transplantation. The

bacterial culture was negative but the sample tested positive for

RSV-A with a high viral load (Ct value of 23). Follow up samples 15

days and 35 days post-surgerywere still RSV positive althoughwith

decreasing viral load (Ct value of 25 and 28 respectively). Culture of

respiratory samples showed the presence of

Staphylococcus aureus

only 10 days after surgery so RSV is most probably the primary

cause of the respiratory disease. RSV was still detectable 1 month

after transplantationwhichmight be explained by the immunosup-

pressive treatment of the patient. The heart transplantation was

performed during the RSV season. Some days before the surgery

the lady had taken care of her young grandchildren so there indeed

was a potential risk of community-acquired transmission.

Conclusion:

Without testing for viral pathogens no accurate

diagnosis for the respiratory failure of this patient could have been

made. Since screening of adult patients for viral pathogens is not

common practice at the IC-unit, this case illustrates the added value

of molecular screening when signs of respiratory failure arise in

adult immunocompromised patients.

http://dx.doi.org/10.1016/j.jcv.2016.08.191

Abstract no: 148

Presentation at ESCV 2016: Poster 152

Respiratory viruses in the intensive care unit:

More frequent than expected

A. Vankeerberghen

, K. Dierickx, A. Boel,

K. Van Vaerenbergh, H. De Beenhouwer

Laboratory of Microbiology, OLVZ Aalst, Belgium

In the Laboratory of Microbiology of the OLV Hospital in Aalst

respiratory samples (

n

= 3500/year), received from multiple hos-

pitals spread all over Flanders, are analysed on a daily basis by

in house multiplex real time PCR for a panel of viral and bacte-

rial pathogens. The panel includes adenovirus, bocavirus, human

metapneumovirus (hMPV), respiratory syncytial virus (RSV), para-

influenzavirus (PIV) 1, 2, 3 and 4, Influenza virus A and B,

enterovirus, rhinovirus, coronaviruses,

Bordetella pertussis & para-

pertussis, Mycoplasma pneumoniae

and

Chlamydia pneumoniae

.

Before 2014, the majority of samples originated from children.

The severe influenza epidemic in the winter season 2014–2015

made clinicians aware that viral infections in adults are not that

innocent at all. Moreover, in the “Influenza season”, not only

Influenza circulated but also other viruses were cause of severe

disease. Correct identification of the pathogen is indispensable to

administer or withhold therapy. As a consequence, the request for

the real time PCR respiratory panel on samples from adult hospi-

talized patients increased.

In order to calculate the frequency of these pathogens in adult

critically ill patients, a retrospective study was performed for the

period September 2014 to May 2016 including patients transferred

to the coronary care unit (CCU) and the intensive care unit (ICU)

because of respiratory failure.

Respiratory panel results of samples, obtained in the window

from 3 days before to 5 days after transfer to the CCU and IC units,

were included. From the 126 samples, 44 samples were positive

(34.92%) with 41 samples (93.18%) positive for a viral pathogen and

3 samples (6.82%) positive for a bacterial pathogen (1

M. pneumo-

niae

, 1

C. pneumoniae

and 1

B. parapertussis

). None of the samples

were positive for adenovirus or parainfluenzavirus.

As expected, Influenza A virus (

n

= 14) and Influenza B virus

(

n

= 8) were the most frequent and 1 patient had a co-infection of

both viruses. No other co-infection was found. Surprisingly, rhi-

novirus (

n

= 8) was found to be the third most frequent viral cause

of infection. hMPV and RSV are known to cause severe respiratory

problems in infants and RSV infections have also been observed in

the immunocompromised host. In our study, not only RSV (

n

= 5)

but also hMPV (

n

= 7) was found frequently and caused very severe

“Influenza-like” disease.

We can conclude that viral infections are a common cause of

respiratory problems in the intensive care unit and screening of

these patients might be an important clue in diagnosis and correct

treatment.

http://dx.doi.org/10.1016/j.jcv.2016.08.192

Abstract no: 161

Presentation at ESCV 2016: Poster 153

Multidrug-resistant cytomegalovirus infection

in a pediatric stem cell transplantation patient

T. Bauters

1 ,

, L. Florin

2

, V. Bordon

3

, R. Snoeck

4

,

G. Andrei

4

, S. Gillemot

4

, P. Fiten

4

,

G. Opdenakker

4

, G. Laureys

3

, E. Padalko

2

1

Department of Pharmacy, Ghent University

Hospital, Ghent, Belgium

2

Department of Clinical Chemistry, Microbiology

and Immunology, Ghent University and Hospital,

Ghent, Belgium

3

Department of Pediatric Hemato-Oncology and

Stem Cell Transplantation, Ghent University

Hospital, Ghent, Belgium

4

Rega Institute for Medical Research, Department of

Microbiology and Immunology, KU Leuven, Leuven,

Belgium

Background:

Cytomegalovirus (CMV), a member of the

Her-

pesviridae

family, is characterized by a lifelong latency in the host.

Clinical presentations of CMV infection are minimal in immuno-